Merida Merger Corp. I (NASDAQ:MCMJ) announced this afternoon that its shareholders have approved its combination with cannabis enterprise Leafly in a special meeting held this morning.
Although the 8-K filing did not disclose redemption amounts, MCMJ traded below its trust value throughout its redemption deadline January 28, and fell 8.42% today, closing at $6.53.
The SPAC brought in $30 million in additional financing in mid January, but also pushed back its shareholder vote until today to accommodate the changes. The new money came in the form of convertible notes from Cohanzick Management and its affiliates, and will hold an interest rate of 8% per annum, maturing in 2025.
The proceeds from these notes are applicable to the transaction’s $85 million minimum cash condition, but cannot clear it on its own, even when combined with backstop agreements Merida I announced on December 27. The backstops ensured that up to 3,200,000 shares are not redeemed in connection with the completion vote and Merida I’s sponsor originally pledged to provide $10 million in additional funding should the minimum cash condition not be met.
Nonetheless, the parties expect to close the deal shortly, and the combined company is expected to trade on the Nasdaq under the symbol “LFLY”.
Merida I initially announced its $385 million combination with Leafly on August 9. Seattle-based Leafly manages a marketplace of cannabis product sellers with reviews, articles and a database of strains available to legal consumers.
In November, Leafly announced $31 million in revenue for 2021 through the third quarter, representing 14% growth over the same period in 2020.
ADVISORS
- Oppenheimer & Co. served as exclusive financial advisor to Leafly
- Weil, Gotshal & Manges LLP served as Leafly’s legal advisor.
- EarlyBirdCapital, Inc. served as financial advisor to Merida.
- Craig-Hallum Capital Group LLC, JMP Securities, LLC, and The Benchmark Company, LLC are serving as capital markets advisors to Merida.
- Graubard Miller acted as Merida’s legal advisor.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...